Open access · OA
via Europe PMC
Insulin-like growth factor receptor signaling in physiology and disease.
Dilawar M, Malik A, Liao J, Shen P, Huang Z, Zhang P, Wang J, Zhang N, Nisar MF, Chen G.
Signal transduction and targeted therapy · 2026
Abstract
The insulin-like growth factor (IGF) signaling pathway plays a pivotal role in regulating a myriad of cellular and physiological processes, including cell proliferation, differentiation, and the maintenance of redox homeostasis. This review provides a comprehensive overview of the IGF/IGF receptor (IGFR) signaling axis, outlining its historical milestones and delineating its evolution from foundational discoveries to contemporary advancements. We elucidate the structural components of pathway, including ligands, receptors, and IGF-binding proteins, and discuss how multilevel regulation integrates upstream signals with downstream effectors such as the PI3K-AKT and MAPK/ERK pathways. Particular emphasis is placed on the crosstalk between IGF signaling and other pathways, including insulin, EGFR, PDGFR, VEGF, Wnt/β-catenin, JAK-STAT, and TGF-β/BMP in homeostasis and pathophysiological processes. We further discuss the role of IGF signaling in pathological process, highlighting insights from animal models and its implication in a wide range of human diseases, including cancer, cardiovascular diseases, neurodegenerative conditions, metabolic syndromes, skeletal abnormalities, and autoimmune and rare genetic disorders. Finally, we examine the therapeutic potential of targeting the IGF/IGFR axis, current clinical research advancements, FDA-approved pharmacological agents, and ongoing clinical trials. By incorporating historical insights with up-to-date scientific breakthroughs, our review underscores the need for systems-level and context-specific approaches to better understand IGF signaling dynamics, thus paving the way for the development of precision and personalized therapeutic strategies.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- Europe PMC
- DOI
- 10.1038/s41392-026-02843-w
- Canonical
- link ↗
- Fetched
- 2026-10-11 MST
Cite this
APA
M, D., A, M., J, L., P, S., Z, H., P, Z., J, W., N, Z., MF, N., & G., C. (2026). Insulin-like growth factor receptor signaling in physiology and disease. <em>Signal transduction and targeted therapy</em>. https://doi.org/10.1038/s41392-026-02843-w
Vancouver
M D, A M, J L, P S, Z H, P Z, et al. Insulin-like growth factor receptor signaling in physiology and disease. Signal transduction and targeted therapy. 2026. doi:10.1038/s41392-026-02843-w.
BibTeX
@article{dilawar2026Insuli,
title = {Insulin-like growth factor receptor signaling in physiology and disease.},
author = {Dilawar M and Malik A and Liao J and Shen P and Huang Z and Zhang P and Wang J and Zhang N and Nisar MF and Chen G.},
journal = {Signal transduction and targeted therapy},
year = {2026},
doi = {10.1038/s41392-026-02843-w},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Biomedicines 2023
Open access · CC-BY
Mitochondria and Brain Disease: A Comprehensive Review of Pathological Mechanisms and Therapeutic Opportunities
Expert Opinion on Therapeutic Targets 2010
Citation only
Targeting mitochondrial dysfunction in neurodegenerative disease: Part I
Biomolecules 2026
Open access · OA
Sirtuins in Medicine: Multifaceted Roles in Physiological Processes and Cardiovascular Diseases.
International Journal of Molecular Sciences 2024
Open access · CC-BY
mTOR: Its Critical Role in Metabolic Diseases, Cancer, and the Aging Process
Biomedicines 2022
Open access · CC-BY
Therapeutic Antiaging Strategies
Molecular neurobiology 2026
Open access · OA